Janney Montgomery Scott
MIRM icon

Janney Montgomery Scott’s Mirum Pharmaceuticals MIRM Stock Holding History

Janney Montgomery Scott’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Sell
2,900
-300
-9% -$28.2K ﹤0.01% 2463
2025
Q4 		$253K Buy
3,200
+200
+7% +$14.4K ﹤0.01% 2664
2025
Q3 		$220K Buy
+3,000
New +$191K ﹤0.01% 2682
2024
Q2 		– Sell
-14,812
Closed -$372K – 2737
2024
Q1 		$372K Sell
14,812
-9,288
-39% -$255K ﹤0.01% 2196
2023
Q4 		$711K Buy
24,100
+5,175
+27% +$157K ﹤0.01% 1663
2023
Q3 		$598K Buy
18,925
+950
+5% +$26K ﹤0.01% 1649
2023
Q2 		$465K Buy
17,975
+100
+0.6% +$2.66K ﹤0.01% 1913
2023
Q1 		$429K Sell
17,875
-450
-2% -$10.3K ﹤0.01% 1814
2022
Q4 		$357K Sell
18,325
-1,100
-6% -$21.7K ﹤0.01% 1990
2022
Q3 		$408K Buy
19,425
+2,700
+16% +$65K ﹤0.01% 1822
2022
Q2 		$308K Buy
16,725
+3,100
+23% +$73.1K ﹤0.01% 1901
2022
Q1 		$300K Buy
+13,625
New +$278K ﹤0.01% 1880

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Janney Montgomery Scott's MIRM Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Mirum Pharmaceuticals (MIRM) stake by 9.4% in Q1 2026, selling an estimated $28.2K and leaving 2,900 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

Janney Montgomery Scott first reported a position in MIRM in Q1 2022 and has held it in 12 quarters since. The position peaked at $711K in Q4 2023. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Janney Montgomery Scott held 2,900 shares of Mirum Pharmaceuticals worth $268K as of Q1 2026.
  • Janney Montgomery Scott sold 300 Mirum Pharmaceuticals shares in Q1 2026, an estimated $28.2K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2463 holding.
  • Janney Montgomery Scott first reported a position in Mirum Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
  • Janney Montgomery Scott's Mirum Pharmaceuticals position peaked at $711K in Q4 2023.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.